Pearls & Perspectives: Rethinking Pelvic Pain and Bladder Health, with Heather Florio

Welcome back to Pearls & Perspectives!

In this episode of Pearls & Perspectives, host Amy Pearlman, MD, sits down with Heather Florio to explore the evolving role of nonhormonal therapies and nutraceuticals in pelvic and bladder health. Framed against the backdrop of renewed national attention on hormone replacement therapy following the recent removal of boxed warnings on menopausal hormone therapy,¹ the conversation examines how clinicians can think more broadly about individualized care for women with complex pelvic pain and urinary symptoms.

Florio, CEO and second-generation owner of the family-owned company Desert Harvest, shares the personal story behind the company’s founding after her aunt’s diagnosis with interstitial cystitis (IC) in the early 1990s. She discusses how that experience led her family to investigate aloe vera–based therapies for IC and chronic pelvic pain, eventually developing the company’s signature super-strength aloe vera (SSAV) formulation. Throughout the discussion, Florio emphasizes the importance of combining conventional medicine with evidence-informed complementary therapies rather than viewing them as competing approaches.

Pearlman and Florio also delve into the challenges clinicians face when managing patients with chronic urinary symptoms, recurrent urinary tract infections, pelvic pain, and IC—conditions that often require extensive evaluation and multimodal treatment strategies. Florio highlights emerging research on phenotyping IC, the possible relationship between menopause and bladder dysfunction, and the limitations of current diagnostic paradigms. The conversation also addresses the growing interest in pelvic floor dysfunction, microbiome health, and autoimmune mechanisms as potential contributors to chronic bladder symptoms.

A major focus of the episode centers on supplement quality, regulation, and scientific validation. Florio discusses the company’s efforts to fund clinical research, including randomized placebo-controlled studies and ongoing trials investigating SSAV. She explains why supplement formulation, third-party testing, ingredient sourcing, and manufacturing standards matter, particularly in a market often crowded with poorly validated products and marketing-driven claims. The discussion also explores several Desert Harvest products beyond SSAV, including quercetin formulations for histamine-related bladder flares, low-acid multivitamins designed for patients with bladder sensitivity, probiotics tailored for inflammatory conditions, and lactoferrin-based products being studied for menopausal and immune-related applications.

Throughout the episode, Pearlman brings a clinician’s perspective to the discussion, asking practical questions about how clinicians can evaluate nutraceuticals, counsel patients about over-the-counter therapies, and determine which patients may benefit from adjunctive nonpharmacologic approaches. Together, Pearlman and Florio underscore the importance of evidence generation, patient-centered care, and nuanced clinical decision-making in an area of medicine where many patients continue to struggle for answers.

REFERENCE

1. HHS advances women’s health, removes misleading FDA warnings on hormone replacement therapy. News release. US Food & Drug Administration. November 10, 2025. Accessed May 14, 2026. https://www.fda.gov/news-events/press-announcements/hhs-advances-womens-health-removes-misleading-fda-warnings-hormone-replacement-therapy-0